Key Takeaways
- • Activist hedge fund Toms Capital Investment Management (TCIM) has built a significant stake in Voya Financial and is pressuring the company to pursue a sale or divest its health insurance operations, according to PYMNTS reporting.
- • TCIM has established a track record of activist intervention across multiple sectors, having previously pushed for strategic changes at Kellanov, US Steel, and Kenvue before its $40 billion acquisition by Kimberly-Clark in late 2025.
- • The hedge fund, founded in 2017 and based in New York, operates with discretionary trading authority over private pooled investment vehicles and separately managed accounts, positioning it as a meaningful player in activist capital deployment.
- • Voya Financial's shares have risen on the activist pressure announcement, reflecting investor optimism that the campaign could unlock shareholder value through structural changes or a full or partial exit.
- • The size of TCIM's stake in Voya and its specific strategic demands remain undisclosed, leaving room for negotiation and potential escalation if management resists the activist's positioning.
Summary
Toms Capital Investment Management (TCIM), an activist hedge fund founded in 2017 with principal offices in New York, has acquired a significant stake in Voya Financial and is pressuring the asset manager and insurance company toward a sale or material divestiture of its health insurance operations. According to PYMNTS, the hedge fund's involvement has already lifted market sentiment around Voya, with shares rising on the announcement, though the precise size of TCIM's position and its detailed strategic demands have not been publicly disclosed.
TCIM's activist campaign at Voya fits a broader pattern of interventionist activity across the financial services and industrial sectors. The hedge fund previously built stakes in Kellanov (formerly Kellogg Company), US Steel, and Kenvue, the Tylenol and consumer health subsidiary spun from Johnson & Johnson. Most notably, TCIM's involvement preceded Kenvue's $40 billion sale to Kimberly-Clark in late 2025, establishing the fund's credibility in identifying value-creation opportunities through forced strategic action. The fund operates with discretionary trading authority over private pooled investment vehicles and separately managed accounts, giving it substantial operational flexibility in pursuing activist agendas.
Voya Financial operates in the highly consolidated pension, retirement, and insurance sectors, where activist investors have increasingly focused attention on mixed-portfolio conglomerates trading at perceived discounts to sum-of-the-parts valuations. TCIM's push for a sale or divestiture reflects a thesis that Voya's health insurance operations may be dragging on overall valuation multiples or that the company would command stronger prices through a separation strategy or full acquisition. The timing of this campaign suggests that activist investors remain confident in identifying undervalued financial services assets despite broader market volatility and regulatory uncertainty affecting the sector.
For institutional investors and family offices tracking activist dynamics, TCIM's emergence as a focused activist operator warrants monitoring, particularly given its demonstrated success in prior campaigns and its apparent focus on financial services and industrial consolidation opportunities. The lack of disclosed negotiating positions and stake size creates optionality—depending on how Voya's board and management respond, outcomes could range from strategic asset sales to a full company acquisition, each with materially different implications for shareholders and creditors.
TCIM's activist campaign at Voya fits a broader pattern of interventionist activity across the financial services and industrial sectors. The hedge fund previously built stakes in Kellanov (formerly Kellogg Company), US Steel, and Kenvue, the Tylenol and consumer health subsidiary spun from Johnson & Johnson. Most notably, TCIM's involvement preceded Kenvue's $40 billion sale to Kimberly-Clark in late 2025, establishing the fund's credibility in identifying value-creation opportunities through forced strategic action. The fund operates with discretionary trading authority over private pooled investment vehicles and separately managed accounts, giving it substantial operational flexibility in pursuing activist agendas.
Voya Financial operates in the highly consolidated pension, retirement, and insurance sectors, where activist investors have increasingly focused attention on mixed-portfolio conglomerates trading at perceived discounts to sum-of-the-parts valuations. TCIM's push for a sale or divestiture reflects a thesis that Voya's health insurance operations may be dragging on overall valuation multiples or that the company would command stronger prices through a separation strategy or full acquisition. The timing of this campaign suggests that activist investors remain confident in identifying undervalued financial services assets despite broader market volatility and regulatory uncertainty affecting the sector.
For institutional investors and family offices tracking activist dynamics, TCIM's emergence as a focused activist operator warrants monitoring, particularly given its demonstrated success in prior campaigns and its apparent focus on financial services and industrial consolidation opportunities. The lack of disclosed negotiating positions and stake size creates optionality—depending on how Voya's board and management respond, outcomes could range from strategic asset sales to a full company acquisition, each with materially different implications for shareholders and creditors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.